Fatih Kemik

5PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2026
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.

|Sep 08, 2026
Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer.

|May 04, 2026
Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.

|Mar 28, 2026
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCR.

Ayberk Bayramgil, Mehmet Haluk Yücel, Ezgi Turkoglu

|Mar 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.

Taha Koray Sahin, Fatih Kemik, Harun Muglu

Pageof 1

Frequent Collaborators

3 joint publications

Bahadır Köylü

3 joint publications

Mehmet Haluk Yücel

2 joint publications

Cevat İlteriş Kıkılı

2 joint publications

Nazan Demir